![](/img/cover-not-exists.png)
C06PET-FDG as a predictor of efficacy of Sunitinib in patients with metastatic GIST, progressing after treatment of Imatinib 400 mg/day:
Badalamenti, G., Fulfaro, F., Ancona, C., Vincenzi, B., Grignani, G., Bartolotta, S., Incorvaia, L., Piazza, D., Russo, A.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv338.06
Date:
October, 2015
File:
PDF, 32 KB
english, 2015